More isn’t always better, precision is. Understanding dosage in immunotherapy is complex. We’re breaking down the science of cell counts and how we determine the specific strength needed to target your unique case at Cancer Killer Cells.
Learn the science behind the dosage. https://justpaste.it/f7926
: #PrecisionMedicine #CancerFighter #Biotech #NKCells #CancerKillerCells
The hardest part of beating cancer is the fear of it coming back. Learn how "Immune Surveillance" via NK cells acts as a 24/7 security system to mop up micro-metastases before they turn into a relapse. Here is the science behind reducing recurrence risk.
Protect Your Future! https://justpaste.it/n0d52
Navigating the complex landscape of Cell Therapy China?
From Stem Cell repair to NK Immune therapies, China offers cutting-edge options—but separating the medical reality from marketing hype is crucial.
Read article:https://zurl.co/Ce4RD
As a trusted medical concierge provider, MedBridgeNZ connects you to compliant, top-tier institutions and specialists for a safe Medical Tourism China experience.
#CellTherapy #StemCellT #StemCells #NKCells #China #MedicalTourismChina #ChinaMedicalTourism
Key Takeaways • Two Main Types: Cell Therapy in China is primarily divided into Stem Cell Therapy (tissue repair) and Immune Cell Therapy (defense/cancer fighting). • Legal Status: Commercial stem cell treatments are strictly regulated. The Boao Lecheng Pilot Zone is the only region in mainland China legally authorized for broad commercial application. • Cost Reality: Legitimate therapies in the pilot zone are premium services, often ranging from $5,000 to over $100,000 USD depending on the regi
Perforin is the substance T and NK cells use to drill into an infected cell and kill it. Selin and Gill’s studies suggest that ME/CFS and long-COVID patients’ T cells produce almost no perforin
https://www.healthrising.org/wp-content/uploads/2025/05/Perforin_Selin_Webinar_25.gif
[alt text: graphs of perforin in two classes of cell. The healthy controls are tall grey bars, compared to 1/10 to 1/3 as tall bars for Long COVID and ME/CFS groups.]
they also found
a huge increase in a distinct type of T-cell called double-positive T-cell (CD4+ CD8+) in people with ME/CFS and/or long COVID. Instead of being differentiated into the two usual major T-cell subsets CD4 (helper/regulatory) and CD8 (killer) T-cells, these hybrid T-cells look like both CD4 and CD8 T-cells at the same time.
Selin found that these cells increased 8-9 fold in ME/CFS and long-COVID patients.
which compensates in part for the lower perforin, but also led to
a “highly dysregulated” cytotoxic T-cell immune response [...] That suggested that the immune system was kind of flailing around, trying to come up with an answer.
from https://www.healthrising.org/blog/2025/05/15/t-cell-exhaustion-chronic-fatigue-long-covid/
#COVID #COVID19 #MECFS #LongCOVID #CovidIsNotOver #TCells #NKCells #CD8 #CD4
Natural killer cells with memory? Scientists just discovered they can target ovarian cancer like pros—redefining immunotherapy potential. #CancerResearch #Immunotherapy #NKcells
https://geekoo.news/natural-killer-cells-show-cancer-fighting-memory/
Episode 5 of the Cell Therapy Podcast is out, this time about NK cells cells: How do they function and can we utilize them as a cellular therapy?
In this episode we are joined by Dr Arnika Wagner & Dr Evren Alici both from the Karolinska Institutet and Dr Sigrid Skånland from Olso University Hospital for a chat about these exciting cells and how their anti-cancer effects are explored - and can be used in the future.
Check it out: https://open.spotify.com/episode/5KPP7aUbRf75ewSijrUBsY?si=IIHr4vd7T428DyPII93Mng
Listen to this episode from The Cell Therapy Podcast on Spotify. What are NK cells, how do they function and how can we utilize them as a cellular therapy? In this episode we are joined by Dr Arnika K. Wagner and Dr Evren Alici, both from Center for Hematology and Regenerative Medicine at Karolinska Institutet, and Dr Sigrid Skånland from Institute for Cancer Research at Olso University Hospital for a chat about these exciting cells and how their anti-cancer effects are explored and can be used in the future.In this episode we discuss the following articles: Arnika K. Wagner et al, PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotype, iScience, 2022 Sigrid S Skånland et al, Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case, Haematologica, 2022. Hareth Nahi et al, Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma, Cell Reports Medicine, 2022. Arnika K. Wagner et al, Characterization of human natural killer cells for therapeutic use, Cytotherapy, 2019. Katharina H. Susek, Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy, Cancer Immunology, Immunotherapy, 2023. You can follow Dr Sigrid S Skånland at @SigridSkanland and Dr Evren Alici at @ealici on Twitter.
Sonya Lopez
Biohacking Pathway
MedBridgeNZ
datum (n=1)
Geekoo
Brad Mitchell
halama_immuno
Mike Barnkob